---
title: "Pharming Group NV (PHAR.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PHAR.US/norm.md"
symbol: "PHAR.US"
name: "Pharming Group NV"
parent: "https://longbridge.com/en/quote/PHAR.US.md"
datetime: "2026-05-21T14:22:55.101Z"
locales:
  - [en](https://longbridge.com/en/quote/PHAR.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PHAR.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PHAR.US/norm.md)
---

# Pharming Group NV (PHAR.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.0700 | 0.0722 | 0.1503 | 0.0663 | -0.2200 |
| ROE | -7.64% | 7.87% | 11.98% | 8.28% | -27.07% |
| Revenue | 72.45M | 106.53M | 97.29M | 93.22M | 79.09M |
| Net income | -5.21M | 5.33M | 7.55M | 4.69M | -14.72M |
| Operating income | -4.91M | 3.03M | 25.92M | 3.05M | -7.04M |
| Gross margin | 90.83% | 80.16% | 92.73% | 90.38% | 89.48% |
| Net margin | -7.20% | 5.00% | 7.76% | 5.04% | -18.61% |
| Profit quality | -251.59% | 28.29% | 80.94% | 25.96% | -3036.21% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 489.37M | 499.96M | 473.79M | 446.26M | 403.18M |
| Leverage | 1.82 | 1.80 | 1.79 | 1.86 | 1.87 |
| BVPS | 3.61 | 3.95 | 5.27 | 3.50 | 3.20 |
| Turnover | 0.8279 | 0.8359 | 0.8057 | 0.7883 | 0.7592 |
| Cash & STI | 170.18M | 179.10M | 166.17M | 126.01M | 107.27M |
| Inv & Rec | 64.58M | 64.90M | 67.14M | 63.72M | 59.35M |
| LT assets | 23.10M | 23.97M | 24.99M | 24.57M | 24.23M |
| Net debt | -53.97M | -63.33M | -35.25M | 2.32M | 11.87M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 1.95M | 10.71M | 32.03M | 11.74M | 232000.00 |
| Investing CF | -84.76M | -45000.00 | -349000.00 | 16.95M | 9.69M |
| Financing CF | -9.22M | 1.04M | 9.93M | -2.76M | -6.72M |
| Free CF | -4.82M | 29.27M | 30.24M | 4.65M | 6.32M |
| OCF coverage | 14.77% | 654.06% | 2746.66% | 983.50% | 23.27% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -238000.00 | -269000.00 | -70000.00 | -128000.00 | -282000.00 |